• Photo
Dr. Harvey Fineberg from the US, chairman of the International Health Regulations Review Committee

Dr. Harvey Fineberg from the US, chairman of the International Health Regulations Review Committee, briefs the press. (AP Photo/Keystone/Martial Trezzini)

  • More International News
Saudi to expel Hezbollah…

BEIRUT (AP) — The Saudi envoy to Lebanon says the kingdom will deport Lebanese citizens …

China sex tape official: I'm a…

BEIJING (AP) — Call me a lecher but don't call me a crook, an ex-city official at the …

Iraqis vote in 2 Sunni-…

BAGHDAD (AP) — Iraqis in two Sunni-dominated provinces where provincial elections had …

Singapore haze at worst yet,…

SINGAPORE (AP) — Singapore urged people to remain indoors amid unprecedented levels of …

Italian icons find no respite…

MILAN (AP) — Sophia Loren wore green silk and sunglasses for her date with the taxman, …

Advertisement
  • Report It!

When you see it happening - Report It!

When you know it's going on, when you see it happening  - Report It!

Expert group to view swine flu papers

Finished report due out next year

Updated: Wednesday, 19 May 2010, 9:08 AM MDT
Published : Wednesday, 19 May 2010, 6:16 AM MDT

GENEVA (AP) - An expert panel investigating the World Health Organization's response to last year's swine flu outbreak said Wednesday it wants to see confidential exchanges between the U.N. body and drug companies.

The 29-member panel will seek WHO records and correspondence from before and after the H1N1 strain was declared a pandemic in June, said committee chairman Harvey Fineberg, who is also president of the Institute of Medicine in Washington.

"We will want to have access to certain confidential documents that may be in place here at WHO or elsewhere," Fineberg told reporters in Geneva.

The documents include "contractual or letters of understanding" between the pharmaceutical industry and WHO, he said. "Some of the agreements with industry that we would like to examine have been considered confidential," but so far all of the panel's requests have been met, he said.

WHO spokesman Gregory Hartl said he couldn't immediately comment.

Under criticism for how the outbreak was handled, WHO Director-General Margaret Chan convened the panel last month and urged its members to conduct a "credible and independent review" that she promised would be transparent.

The Geneva-based agency has denied allegations that it gave pharmaceutical companies privileged access to national decision-makers.

Governments around the world spent millions of dollars (euros) buying antiviral drugs and flu vaccines in anticipation of a serious outbreak that never happened.

Among the companies that benefited was Switzerland's Roche Group, which saw sales of its Tamiflu antiviral medication jump by 2 billion Swiss francs ($1.74 billion) last year. British firm GlaxoSmithKline PLC sold both vaccines and its antiviral Relenza, while France's Sanofi-Aventis SA and U.S.-based Baxter International made vaccines. Some companies donated medicine to poor countries.

WHO has confirmed 18,036 deaths from the H1N1 strain over the past year — far fewer than would have died from seasonal flu during the same period.

Chan said this week at a meeting of WHO's 193 member states that the world had been "just plain lucky" that swine flu wasn't deadlier.

The panel's final report is expected to be finished next year, and will be made public, Fineberg said.

  • Comments
Comment With KRQE.com's commenting system, you don't need to register. You can login with an existing Facebook, Yahoo!, Google, or Twitter account and more. 
 

powered by Disqus

Report It to KRQE News 13

Advertisement
Advertisement

Advertisement

Explore Featured Content »